Results of an Australian trial of an automated insulin delivery (AID) system and other studies support likely benefit of AID use for many Australian adults with type 1 diabetes

The Australian JDRF Closed-Loop Research Group, Mary B. Abraham, Elizabeth A. Davis, Joey Kaye, Timothy W. Jones

Research output: Contribution to journalArticlepeer-review

Abstract

Less than 20% of Australians with type 1 diabetes (T1D) meet recommended glucose targets. Technology use is associated with better glycaemia, with the most advanced being automated insulin delivery (AID) systems, which are now recommended as gold-standard T1D care. Our Australian AID trial shows a wide spectrum of adults with T1D can achieve recommended targets. Other studies, including lived experience data, are supportive. Insulin pumps are not subsidised for most Australian adults with T1D. We advocate change.

Original languageEnglish
Pages (from-to)148-153
Number of pages6
JournalInternal Medicine Journal
Volume55
Issue number1
Early online date27 Nov 2024
DOIs
Publication statusPublished - Jan 2025

Fingerprint

Dive into the research topics of 'Results of an Australian trial of an automated insulin delivery (AID) system and other studies support likely benefit of AID use for many Australian adults with type 1 diabetes'. Together they form a unique fingerprint.

Cite this